Subscribe
Facebook Twitter Instagram Youtube

WHA at ALEH 2021

¡Inscripciones abiertas para Panel de Sociedad Civil y Hepatitis durante el Congreso ALEH 2021 ONLINE! El tema es “Rol de las organizaciones de pacientes para alcanzar las metas de OMS en la eliminación de las hepatitis virales”

24 abril 2021 a las 10 AM hora de Rio de Janeiro

Inscríbete SIN COSTO ingresando a https://eventual.meinscribo.cl/evento/67

y marcando Panel Sociedad Civil y Hepatitis | Sala 2 | 24-04-2021

Puedes ver el programa aquí: https://congresoaleh.com/wp-content/uploads/2021/04/Programa-aleh-actualizado-19-abr.pdf

 Te recomendamos inscribirte a los demás eventos del congreso pagando la cuota correspondiente. El programa está muy interesante. Visita la web del congreso aquí: https://congresoaleh.com/

English version

Registration is open for the Civil Society and Hepatitis Panel during the ALEH 2021 ONLINE Congress! The theme is “Role of patient organizations to achieve the WHO goal of the elimination of viral hepatitis”

April 24, 2021 at 10 AM Rio de Janeiro time

Sign up for FREE by going to https://eventual.meinscribo.cl/evento/67 and ticking the ‘Civil Society and Hepatitis Panel | Room 2 | 04-24-2021’

You can see the program here: https://congresoaleh.com/wp-content/uploads/2021/04/Programa-aleh-actualizado-19-abr.pdf

We recommend that you register for the other events of the congress by paying the corresponding fee. The program is very interesting. Visit the congress website here: https://congresoaleh.com/

Latest News

Sign up to receive updates from WHA

Name(Required)
I would like to hear about(Required)
Confirm consent(Required)

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Hepatitis and PWID/harm reduction 

 

11:35 – 11:40  

Chair: WHO – Intro and set the scene.  

 

11:40 – 11:55  

Co-chair:  EMCDDA – Monitoring viral hepatitis elimination among PWID in Europe. 

 

11:55 – 12:00 

ID 29: Ema Pos (not yet registered) 

Title: If the mountain won’t come to Mohammed: lessons from a decentralized Infectious Disease consultation. 

 

12:05 – 12:10  

ID 152: Brian Conway (Registered in person) 

Title: Community Pop-up Clinic: Cascade of Care and HCV Treatment of Vancouver’s inner-city PWID Populations.

 

12:10 – 12:15 

ID 212: Jasmine West (not yet registered) 

Title: From lived experience to lived expertise: a syndemic approach. 

 

12:15 – 12:20 

ID: 299 Mercy Nyakowa (Registered in person) 

Title: HCV and HBV prevalence and associated risk factors among people who inject drugs (PWIDs) in Kenya 

 

12:20 – 12:25 

ID: 133 Nalinikanta Rajkumar (Registered in person) 

Title: Rapid regimen of HBV vaccination: Does it work for high risk groups?  

 

12:25 – 12:30 

Q&A and closing remarks   

tHIS

 

IS 

 

BEN’S

 

 

 

BIG 

 

 

TEST

effective case finding strategies

Supported by Vir Biotechnology, Inc

During this session you will hear from hepatitis Delta expert, Dr. Maria Buti, and a patient who has lived with hepatitis Delta in a panel discussion moderated by Dr. Carey Hwang, Chief Medical Officer (interim) of Vir Biotechnology. This panel will inform perspectives on patient needs, opportunities for enhanced screening, and strengthening linkages to care.

Session Agenda

14:40 – 14:45    

Panel overview and introductions facilitated by Dr Carey Hwang (Vir Biotechnology)

14:45 – 15:05   

Panel discussion: Dr Maria Buti (University Hospital Vall d’Hebron, Spain), Milanka Barbosa, Dr Carey Hwang (Chief Medical Officer interim), Vir Biotechnology

15:05 – 15:10    

Final remarks and close